Diligence memo · auto-generated · as of July 2, 2026

NeuroVice, Inc.

NeuroVice, Inc. looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

NeuroVice, Inc. operates in Other Health Care, based in CHARLOTTE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

NeuroVice, Inc. has raised $270K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $270K on 2025-05-05.

Most recent recorded round closed around 2025-05-05.

Valuation (modeled)modeled

Provath models NeuroVice, Inc. at approximately $752K (range $169K–$2.0M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.91× the median modeled value of Pre-Seed Other Health Care companies in 2025–2027 (116 peers) — value vs value, same stage and era. Within the normal band (91% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 14 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

Comparablesmixed

Capital scale ranks ahead of 13% of Other Health Care peers (5377 compared).

Modeled value ranks above 4% of those peers.

Closest niche peers: 352 Ingredients LLC, Bmh North Mississippi Imaging Services Llc, ClearPath Vascular, Inc., Imagen Silvera Support Services, LLC, Mens LLC.

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.